News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,492 Results
Type
Article (43450)
Company Profile (357)
Press Release (672685)
Section
Business (211596)
Career Advice (2085)
Deals (36349)
Drug Delivery (94)
Drug Development (82102)
Employer Resources (172)
FDA (16653)
Job Trends (15272)
News (355605)
Policy (33327)
Tag
Academia (2683)
Alliances (52210)
Alzheimer's disease (1284)
Approvals (16611)
Artificial intelligence (166)
Bankruptcy (357)
Best Places to Work (11876)
Biotechnology (252)
Breast cancer (192)
Cancer (1397)
Cardiovascular disease (111)
Career advice (1744)
Cell therapy (295)
Clinical research (65495)
Collaboration (506)
Compensation (265)
COVID-19 (2626)
C-suite (115)
Data (1412)
Diabetes (178)
Diagnostics (6437)
Earnings (86498)
Employer resources (151)
Events (114677)
Executive appointments (409)
FDA (17353)
Funding (449)
Gene therapy (205)
GLP-1 (618)
Government (4435)
Healthcare (19414)
Infectious disease (2721)
Inflammatory bowel disease (114)
Interviews (320)
IPO (16686)
Job creations (3814)
Job search strategy (1489)
Layoffs (431)
Legal (8081)
Lung cancer (201)
Manufacturing (212)
Medical device (13942)
Medtech (13947)
Mergers & acquisitions (19837)
Metabolic disorders (470)
Neuroscience (1610)
NextGen Class of 2024 (6832)
Non-profit (4605)
Northern California (1722)
Obesity (265)
Opinion (195)
Parkinson's disease (100)
Patents (126)
People (58670)
Phase I (20526)
Phase II (28823)
Phase III (21399)
Pipeline (517)
Postmarket research (2579)
Preclinical (8800)
Radiopharmaceuticals (254)
Rare diseases (270)
Real estate (6216)
Regulatory (22256)
Research institute (2449)
Resumes & cover letters (361)
Southern California (1493)
Startups (3827)
United States (15642)
Vaccines (594)
Weight loss (188)
Date
Today (127)
Last 7 days (584)
Last 30 days (2431)
Last 365 days (36295)
2024 (36134)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55615)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (754)
Arizona (205)
Asia (39932)
Australia (6637)
California (3909)
Canada (1466)
China (314)
Colorado (178)
Connecticut (185)
Europe (87206)
Florida (541)
Georgia (144)
Illinois (408)
Indiana (231)
Maryland (647)
Massachusetts (3062)
Michigan (192)
Minnesota (300)
New Jersey (1130)
New York (1105)
North Carolina (786)
Northern California (1722)
Ohio (148)
Pennsylvania (939)
South America (1150)
Southern California (1493)
Texas (565)
Utah (113)
Washington State (413)
716,492 Results for "neonc technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
July 16, 2024
·
7 min read
Press Releases
NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate
August 5, 2024
·
6 min read
Biotech Beach
NeOnc Technologies Completes $10.0 Million Equity Funding Round
NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has completed a $10.0 million equity funding round at a post-money valuation of $70 million.
February 8, 2023
·
4 min read
Press Releases
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
July 25, 2024
·
6 min read
Press Releases
BRIJ Medical, Inc. Awarded Breakthrough Technology Agreement in the Non-Invasive Skin Closure Category with Premier, Inc.
December 17, 2024
·
2 min read
Press Releases
MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs)
December 23, 2024
·
10 min read
Press Releases
Healthcare Integrated Technologies, Inc. Welcomes Tim Brady as its Full-Time Chief Financial Officer
December 16, 2024
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC. ANOUNCES DETAILS OF ITS 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 31, 2024
December 23, 2024
·
4 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
News
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
·
1 min read
1 of 71,650
Next
